medigraphic.com
ISSN 0016-3813 (Print)

2016, Number 3

<< Back Next >>

Gac Med Mex 2016; 152 (3)

Initial surgical management of squamous carcinoma of the vulva

Salazar-Báez I, Salazar-Campos JE, López-Arias A, Villavicencio-Valencia V, Coronel-Martínez J, Candelaria-Hernández M, Pérez-Montiel D, Pérez-Plasencia C, Rojas-García AE, Cantú LD

Language: Spanish
References: 22
Page: 297-303
PDF size: 142.81 Kb.


ABSTRACT

Vulvar cancer accounts for approximately 4% of gynecological malignancies. At the Instituto Nacional de Cancerologia in Mexico it occupies the fourth place. The purpose of this study is to assess the management of squamous carcinoma of the vulva with initial surgical treatment. It is a descriptive retrospective, observational study, from January 1, 2002 to December 31, 2012. Twenty-seven patients, clinical stages I, II, or III, initial surgical management, with at least one year of follow-up were included. In 51.85% a partial vulvectomy was performed and in 40.74% a wide excision; 66.66% underwent inguinofemoral dissection. Recurrence occurred in 25.91% of cases and the overall survival at 10 years was 63%. It is concluded that with invasion of up to 1 mm of lymph node, affection is 0%; with invasion of 1 mm and up to 5 mm this increases to 25%; an invasion of more than 5 mm implies up to 45%. Recurrence in our study was primarily distant, necessitating long-term monitoring with emphasis on symptoms to request imaging studies when suspected. Adjuvant therapy should be offered to patients with positive nodes, close or positive margins, and tumors larger than 4 cm.


REFERENCES

  1. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-based Report. Atlanta (GA): Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2014.

  2. I.R.C.P. (2012) Gynecologic Cancers Portfolio Analysis: Summary of the burden of gynecologic cancers in the United States and investments in research by the National Center Institute and members of the International Cancer Research Partnership. Recuperado el 21/11/14, de IRCP Partnership sitio web: https://www.icrpartnership.org/Publications/ICRP_ GYN_analysis.pdf.

  3. Oncoguía Sociedad Española de Ginecología y Obstetricia. Cáncer Escamoso Invasor de Vulva. Guías de práctica clínica en cáncer ginecológico y mamario. Publicaciones S.E.G.O. 2010(3). 978-84-615-5421-8.

  4. Schilder JM, Stehman FB. Invasive Cancer of the Vulva. En: Clinical Gynecologic Oncology. DiSaia P, Creasman WT. (editores). 8a ed. Philadelphia, EUA: Saunders, Elsevier Inc.; 2012. p. 220-44.

  5. Rodríguez C, González E, Guerra A.l. Cáncer de vulva. Más Dermatología. 2008;4:5-13.

  6. SINAIS/SINAVE/DGE/SALUD/Perfil Epidemiológico de los Tumores en México. 2011. ISBN 978-607-460-236-4.

  7. DeSimone CP, Van Ness JS, Cooper AL, et al. The treatment of lateral T1 and T2 squamous cell carcinomas of the vulva confined to the labium majus or minus.Gynecol Oncol. 2007;104(2):390-5.

  8. Bromfield ME, Gibson TN, Hanchard B, Waugh N, McNaughton D. A Thirty-year Review of Vulvar Cancer in Jamaica, 1978 to 2007. West Indian Med J. 2014;2:138-41.

  9. Bosque OJ, Delgado R, Montero JF, Esperón RP, Silveira JM, Aguilar FO. Cáncer de la vulva: cuadro clínico, histopatología y supervivencia (1980 a 2004). Rev. Cubana Cir. 2008;47:4.

  10. Maggino T, Landoni F, Sartori E, et al. Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF study. Cancer. 2000;89:116.

  11. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium, Int J Gynecol and Obstet. 2009;105:103-4.

  12. Martínez-Palones JM, Pérez-Benavente MA, Gil-Moreno A, et al. Comparison of recurrence after vulvectomy and lymphadenectomy with or without sentinel node biopsy in early stage vulvar cancer. Gynecol Oncol. 2006;103:865-70.

  13. Messing MJ, Gallup DG. Carcinoma of the vulva in young women. Obstet Gynecol. 1995;1:51-4.

  14. Heaps JM, Fu YS, Montz FJ, Hacker NF, Berek JS. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol. 1990;3:309-14.

  15. Oonk MH, van der Zee AG. Application of sentinel nodes in gynaecological cancer therapy. EJC Suppl. 2013;11:287-8.

  16. Barton DP, Berman C, Cavanagh D, et al. Lymphoscintigraphy in vulvar cancer: a pilot study. Gynecol Oncol. 1992;3:341-4.

  17. Woelber L, Trillsch F, Kock L, et al. Management of patients with vulvar cancer: a perspective review according to tumour stage. Ther Adv Med Oncol. 2013;3:183-92.

  18. Molero J, Hernández-Aguado JJ, Laila JM. Carcinoma de la vulva. En: Fundamentos de Ginecología, Bajo Arenas JM, Lailla Vicens JM, Xercavins Montosa J. (editores). 1a ed. Madrid, España: Panamericana Inc.; 2009. p. 347-63.

  19. Farias-Eisner R, Cirisano FD, Grouse D, et al. Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T1-2N0-1M0) disease. Gynecol Oncol. 1994;1:55-8.

  20. van der Zee AG, Oonk MH, De Hullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;6:884-9.

  21. Bellati F, Angioli R, Manci N, et al. Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases. Gynecol Oncol. 2005;96:227-31.

  22. Burger MP, Hollema H, Emanuels AG, Krans M, Pras E, Bouma J. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol. 1995;3:327-34.




2020     |     www.medigraphic.com